In particular, these data suggested compromised immune activation might be induced by impairment of MHC class I/IFN-mediated immunosurveillance, which supporting the observations from triple-refractory MM patients [43], and indicated that under treatment pressure, myeloma cells responded at an early timepoint to escape from immune system for its survival and subsequent resistance. Here, IFNA1 is linked to plasma cell myeloma.